Burjeel Holdings has successfully closed its first-ever $500 million sukuk, drawing massive interest from the global financial community. With investor orders peaking at $1.6 billion—more than triple the target amount—the Abu Dhabi-based healthcare leader was able to secure a favorable 7 per cent profit rate. This outcome is particularly notable, as it represents the lowest five-year yield for a private, non-investment-grade issuer in the GCC region since 2020. The offering attracted a diverse pool of backers, with 61 per cent of the allocation going to international investors, including significant participation from the UK and US.

The capital raised will be strategically utilized to refinance existing debt and bolster the company’s ongoing investments in advanced medical technologies, including AI-driven healthcare solutions and research initiatives. Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, noted that the overwhelming demand serves as a testament to the market's faith in the company’s long-term growth and stable financial footing. Following this milestone, the sukuk is scheduled for listing on the London Stock Exchange, marking a significant step in the provider’s efforts to expand its footprint and influence across the UAE, Oman, and Saudi Arabia.